| View |
|
DR-XY35704
|
CIPROFLOXACIN
|
Unbranded
|
3mg/mL(0.3% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Fluroquinolone)
|
E.L. Laboratories, Inc
|
Philippines
|
Renewal
|
10 March 2024
|
21 April 2029
|
| View |
DR-XY35708_PI_01.pdf
|
DR-XY35708
|
LOSARTAN POTASSIUM + HYDROCHLORIDE
|
NEOSARTAN PLUS
|
50 mg/12.50 mg
|
Film-Coated Tablet
|
ANGIOTENSIN II RECEPTOR BLOCKER/DIURETIC
|
Hizon Laboratories, Inc
|
Philippines
|
Renewal
|
19 December 2023
|
22 April 2029
|
| View |
|
DR-XY35723
|
Ascorbic Acid
|
Calcimed
|
500mg (Equi. To 605.20mg Calcium Ascorbate)
|
Capsule
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
02 January 2024
|
22 April 2029
|
| View |
|
DR-XY35742
|
Ceftriaxone (as Sodium)
|
Ceftrox
|
1g
|
Powder for Injection
|
Antibacterial (Third Generation Cephalosporin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
23 February 2024
|
24 April 2029
|
| View |
|
DR-XY35745
|
Atorvastatin (as Calcium)
|
Atopitar
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Geofman Pharmaceuticals
|
Pakistan
|
Renewal
|
08 May 2024
|
27 April 2029
|
| View |
|
DR-XY35746
|
Diclofenac (as Diethylamine)
|
Clogel
|
10 mg/G (1% W/W)
|
Topical Gel
|
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
07 April 2024
|
27 April 2029
|
| View |
|
DR-XY35758
|
Ceftriaxone (as Sodium)
|
Ceftrox
|
250mg
|
Powder For Injection (I.M./I.V)
|
Antibacterial (Cephalosporins)
|
Singapore Pharmawealth Lifesciences, Inc.,
|
Philippines
|
Renewal
|
20 February 2024
|
29 April 2029
|
| View |
|
DR-XY35760
|
Ceftriaxone (as Sodium)
|
Ceftrox
|
500mg
|
Powder for Injection
|
Antibacterial (Third Generation Cephalosporin)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
19 February 2024
|
29 April 2029
|
| View |
|
DR-XY35761
|
Lipids with Omega-3
|
Lipidem
|
Formulation:
Each 1,000 mL emulsion contains:
Medium-chain triglycerides 100 g
Soya-bean oil 80 g
Omega-3 acid triglycerides 20 g
|
Emulsion for Intravenous Infusion
|
Parenteral Nutrition
|
B. Braun Melsungen AG
|
Germany
|
Initial (Variation)
|
30 July 2024
|
30 July 2029
|
| View |
|
DR-XY35781
|
Thiopental Sodium
|
Penthal
|
500mg
|
Powder for Injection (IV)
|
General Anesthetic
|
Oboi Laboratories
|
India
|
Renewal
|
29 March 2024
|
08 July 2029
|
| View |
|
DR-XY35805
|
Betahistine Dihydochloride
|
Betavert
|
8 mg
|
Film-Coated Tablet
|
Anti-vertigo
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
18 May 2022
|
13 May 2027
|
| View |
|
DR-XY35807
|
Betahistine hydrochloride
|
Exigo
|
16 mg
|
Tablet
|
Antivertigo
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
05 May 2024
|
13 May 2029
|
| View |
|
DR-XY35812
|
Ceftriaxone (as sodium)
|
Forgram
|
500 mg
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
PT Darya-Varia Laboratoria Tbk
|
Indonesia
|
Renewal
|
28 April 2024
|
13 May 2029
|
| View |
|
DR-XY35813
|
Ceftriaxone (as sodium)
|
Forgram
|
1g
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
PT Darya-Varia Laboratoria Tbk
|
Indonesia
|
Renewal
|
09 April 2024
|
13 May 2029
|
| View |
|
DR-XY35815
|
Baclofen
|
Trilaxant
|
10 mg
|
Tablet
|
Muscle Relaxant
|
Yoo-Young Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
02 February 2024
|
13 May 2029
|
| View |
|
DR-XY35831
|
Omeprazole
|
Omebloc-20
|
20mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Zee Laboratories
|
India
|
Renewal
|
13 March 2024
|
14 May 2029
|
| View |
|
DR-XY35860
|
Nalbuphine (as hydrochloride)
|
Analin
|
10 mg/mL
|
Solution For Injection (Im/Iv/Sc)
|
Opioid Analgesic
|
Medicaids Pakistan (Pvt.), Ltd.
|
Pakistan
|
Renewal
|
28 April 2024
|
21 May 2029
|
| View |
|
DR-XY35863
|
Clozapine
|
Nirva
|
100mg
|
Tablet
|
Antipsychotic
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 September 2021
|
08 November 2026
|
| View |
|
DR-XY35864
|
Clozapine
|
Nirva
|
25mg
|
Tablet
|
Antipsychotic
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 September 2021
|
08 November 2026
|
| View |
|
DR-XY35876
|
Cetirizine Dihydrochloride + Phenylephrine Hydrochloride
|
Alnix Plus
|
5 mg/ 5 mg per 5 mL
|
Syrup
|
-
|
Amherst Laboratories Inc.
|
Philippines
|
-
|
13 April 2021
|
13 April 2026
|